BlossomHill Therapeutics, Inc. BLSM
13.50 USD +1.15 (+9.31%)
At closeNov 6, 2026, 4:00 PM EST
13.50 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
12.14 Day range 14.09
11.02 52-week range 27.99
- YTD
- -15.63%
- 1 year
- -15.63%
News
globenewswire.com BlossomHill Therapeutics Announces Upcoming Presentation for BH-30236, an Oral Macrocyclic CLK Inhibitor, at the 68th American Society of Hematology (ASH) Annual Meeting SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and…
globenewswire.com BlossomHill Therapeutics to Present at Guggenheim's 3rd Annual Healthcare Innovations Conference SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and…
benzinga.com BlossomHill Therapeutics Collaborates With Foundation Medicine To Develop Companion Diagnostic Assay For EGFR C797S Resistance Mutation BlossomHill Therapeutics, Inc. (NASDAQ:BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines…